ABCA4 病变变异的表达与功能活性与 Stargardt 病表型的相关性
研究对加拿大不列颠哥伦比亚省 11 例 Stargardt 病(STGD1)患者行 ABCA4 外显子及外显子-内含子边界测序,将错义突变在 HEK293T 细胞中表达并测定表达水平、类视黄醇底物结合特性与 ATP 酶活性,并与患者临床表型进行关联分析。结果显示 7 例患者携带两个 ABCA4 突变、3 例检出 1 个突变、1 例在外显子及侧翼区未检出突变;包括 1 例 11 岁重度受累儿童为新发 p.Ala1794Pro 纯合突变。作者认为 ABCA4 突变体的表达与残余活性在决定 STGD1 疾病严重程度中起主要作用。
要点
- 11 例 STGD1 患者中 7 例检出两个 ABCA4 突变、3 例检出 1 个突变、1 例未检出突变。
- 1 例 11 岁重度受累儿童为新发 p.Ala1794Pro 纯合突变。
- 作者认为 ABCA4 突变体表达与残余活性在决定 STGD1 严重程度中起主要作用。
核心结论
- 作者认为尽管多种因素影响 STGD1 患者表型,ABCA4 突变体的表达与残余活性在决定疾病严重程度中起主要作用。
研究设计与样本
- 研究纳入加拿大不列颠哥伦比亚省 11 例确诊 STGD1 患者,对其 ABCA4 外显子及外显子-内含子边界进行测序以识别潜在致病突变。
- 将错义突变在 HEK293T 细胞中表达,测定表达水平、类视黄醇底物结合特性与 ATP 酶活性,并与 STGD1 患者表型进行关联分析。
主要发现
- 11 例 STGD1 患者中 7 例携带两个 ABCA4 突变、3 例检出 1 个突变、1 例在外显子及侧翼区未检出突变。
- 队列中包括 1 例 11 岁重度受累儿童,为新发 p.Ala1794Pro 纯合突变。
- 该变异及其他疾病相关变异的表达与功能分析结果与本队列 STGD1 患者表型较为一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Stargardt disease (STGD1), the most common early-onset recessive macular degeneration, is caused by mutations in the gene encoding the ATP-binding cassette transporter ABCA4. Although extensive genetic studies have identified more than 1000 mutations that cause STGD1 and related ABCA4-associated diseases, few studies have investigated the extent to which mutations affect the biochemical properties of ABCA4. The purpose of this study was to correlate the expression and functional activities of missense mutations in ABCA4 identified in a cohort of Canadian patients with their clinical phenotype. METHODS: Eleven patients from British Columbia were diagnosed with STGD1. The exons and exon-intron boundaries were sequenced to identify potential pathologic mutations in ABCA4. Missense mutations were expressed in HEK293T cells and their level of expression, retinoid substrate binding properties, and ATPase activities were measured and correlated with the phenotype of the STGD1 patients. RESULTS: Of the 11 STGD1 patients analyzed, 7 patients had two mutations in ABCA4, 3 patients had one detected mutation, and 1 patient had no mutations in the exons and flanking regions. Included in this cohort of patients was a severely affected 11-year-old child who was homozygous for the novel p.Ala1794Pro mutation. Expression and functional analysis of this variant and other disease-associated variants compared favorably with the phenotypes of this cohort of STGD1 patients. CONCLUSIONS: Although many factors contribute to the phenotype of STGD1 patients, the expression and residual activity of ABCA4 mutants play a major role in determining the disease severity of STGD1 patients.
引用
- Garces F, Jiang K, Molday LL, et al. Correlating the Expression and Functional Activity of ABCA4 Disease Variants With the Phenotype of Patients With Stargardt Disease. Invest Ophthalmol Vis Sci. 2018. PMID: 29847635. doi:10.1167/iovs.17-23364
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。